Clinical Trials for Trastuzumab (Herceptin)

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCGI1306
07/11/2013
Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel with Trastuzumab in Patients with HER2 Positive Carinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy
TreatmentVICCBRE1304
06/04/2013
A Phase II Study Evaluating the Efficacy and Tolerability of Everolimus (RAD001) in Combination with Trastuzumab and Vinorelbine in the Treatment of Progressive HER2-Positive Breast Cancer Brain Metastases
TreatmentECOGGIR1010
02/28/2013
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.